New Delhi (India), August 31: GoodvedaHealth Labs Pvt Ltd, an innovative Health Tech Startup, has officially entered the Indian market with its groundbreaking health and wellness programs &supplement offerings aimed at combating the escalating concerns of diabetes and obesity. With India witnessing an alarming surge in these chronic conditions, Goodveda’s entry promises a fresh approach to preventive healthcare.
The prevalence of diabetes in India is a pressing health issue, with over 77 million adults affected, according to recent data. Additionally, approximately 135 million Indians are grappling with obesity, a condition that has reached alarming levels in recent years.
Goodveda’s market entry introduces a range of health and wellness programs strategically designed to address diabetes and obesity challenges. These programs are complemented by customized programs for diabetes remission and obesity reversal, seamlessly blending modern scientific advancements with age-old Ayurvedic principles.
Mr. Abhishek Gaggneja, Founder and CEO of Goodveda Health Labs Pvt Ltd, highlights the company’s dedication to holistic health. “Our inception was fueled by the mission of mitigating the burden of chronic diseases,” he commented. “By synergizing modern scientific advancements with the time-tested wisdom of Ayurveda, our programs offer a transformative approach.”
Additionally, Goodveda envisions introducing programs targeting Cardiac Health and Women’s Wellness, underscoring its commitment to comprehensive health interventions.
Central to Goodveda’s innovation is the integration of cutting-edge research and traditional Ayurvedic practices. These programs, founded on evidence-based methodologies, present a harmonious union of modernity and tradition, offering individuals a comprehensive path towards managing their health.
Anchored in delivering measurable results, Goodveda seamlessly merges modern scientific advancements with Ayurvedic traditions, providing rigorously verified programs and a meticulously curated range of products designed to support customers’ health goals.
Goodveda’s commitment to safety, quality, and authenticity is evident through its products, which undergo meticulous testing within state-of-the-art GMP-certified facilities. Certified by both AYUSH and FSSAI, these products underscore Goodveda’s commitment to efficacy, safety, and credibility.
Presently, Goodveda focuses on aiding individuals seeking remission from Diabetes and Obesity. Simultaneously, the company has ambitious plans, with a future expansion into the United States market.
Employing a strategic Direct-to-Consumer (D2C) approach, Goodveda maintains a robust online presence, ensuring seamless access for customers to its transformative health solutions. Through digital platforms, the company effectively engages with its audience, delivering personalized care tailored to individual requirements.
For more information, please visit https://goodveda.com
If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.
